Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
06/1998
06/03/1998EP0844890A1 The use of bile acid derivatives
06/03/1998EP0844889A1 Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands
06/03/1998EP0844886A2 Bioconjugates of manganese complexes and their application as catalysts
06/03/1998EP0844883A1 Use of conotoxin peptides u002 and mii for treating or detecting small-cell lung carcinoma
06/03/1998EP0614527A4 Gel particle contrast media for improved diagnostic imaging.
06/03/1998EP0594640A4 Liposoluble compounds for magnetic resonance imaging
06/03/1998EP0497926B1 Multi-site metal chelating agents
06/03/1998CN1183775A Polyazacycloalkane compounds
06/02/1998US5759994 Antithrombin peptide for cardiovascular disorders
06/02/1998US5759563 Liquid delivery compositions
06/02/1998US5759546 Treatment of CD4 T-cell mediated conditions
06/02/1998US5759518 Metal complexes of dendrimeric macromolecules, diagnostics agents that contain the latter as well as process for the production of the complexes and agents
06/02/1998US5759516 Peptide-metal ion pharmaceutical preparation
06/02/1998US5759515 Polyvalent peptide pharmaceutical applications
05/1998
05/28/1998WO1998022479A1 Pharmaceutical formulations
05/28/1998WO1998022148A1 Mri contrast agents and ligands
05/28/1998WO1998022147A1 Testkit and method
05/28/1998WO1998022146A2 Optical diagnostic agents for diagnosis of neurodegenerative diseases by means of near infra-red radiation (nir radiation)
05/28/1998DE19649971A1 Optische Diagnostika zur Diagnostik neurodegenerativer Krankheiten mittels Nahinfrarot-Strahlung (NIR-Strahlung) Optical diagnostics for the diagnosis of neurodegenerative diseases by means of near infrared radiation (NIR) radiation
05/28/1998DE19648663A1 Flüssigkeitsgefüllte Mikropartikel mit neuem Wirkungsprinzip und deren Verwendung als Diagnostika und Therapeutika Liquid-filled microparticles with a new principle of action and their use as diagnostic and therapeutic agents
05/28/1998CA2272320A1 Optical diagnostic agents for diagnosis of neurodegenerative diseases by means of near infra-red radiation (nir radiation)
05/27/1998EP0843560A1 Cellulose diacetate compositions for use in embolizing blood vessels
05/27/1998EP0843516A1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
05/26/1998US5756723 Metal-mediated cross-coupling with ring-metalated porphyrins
05/26/1998US5756688 Polyether linked to residue of chelating agent having associated paramagnetic metal ion; magnetic resonance imaging
05/26/1998US5756669 Mutants
05/26/1998US5756664 Genetic engineering of proteins with nucleotide sequences for bones
05/26/1998US5756486 Cyclized nucleotide; viricide
05/26/1998US5756069 Hydrophilic polymer
05/26/1998US5756068 Methods of radioimaging and radiochemotherapy using phenolic thioeter amines and acyl derivatives thereof
05/26/1998US5756067 Long chain fatty acid ester of cholesterol labelled with radioactive carbon is used for testing presence of or propensity for atherosclerosis and coronary artery disease
05/26/1998US5756066 Contrast agent for x-ray diagnosis
05/26/1998CA2057053C Recombinant alzheimer's amyloid protein
05/22/1998WO1998020909A2 Ex-corpore method for treating human blood cells
05/22/1998WO1998020908A1 Magnetic resonance blood pool agents
05/22/1998WO1998020904A2 Microparticles filled with liquid acting according to a new principle and their use as diagnostic and therapeutic agents
05/22/1998WO1998020887A1 Polyphosphoinositide binding peptides for intracellular drug delivery
05/22/1998WO1998015277A3 Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agents
05/22/1998WO1998001555A3 Truncated soluble tumor necrosis factor type-i and type-ii receptors
05/20/1998EP0842668A1 Ex-corpore method for treating human blood cells
05/20/1998EP0842425A1 A method of and test kit for mutagenesis testing
05/20/1998EP0841952A1 A method of evaluating an effect of a substance applied to the skin of a mammal
05/20/1998EP0841951A2 Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
05/20/1998EP0841949A2 Saccharide conjugates
05/20/1998EP0841854A1 Novel compositions for use in embolizing blood vessels
05/20/1998EP0717849B1 Assay systems using the cntf signal transduction pathway
05/20/1998EP0708927B1 Methods and compositions for image contrast enhancing
05/20/1998EP0675738B1 Aqueous injectable formulations useful for radio-diagnosis comprising iodinated aromatic compounds used as x-ray contrast media
05/20/1998EP0548157B1 Use of particulate agents
05/20/1998CN1182373A Stabilized gas emulsion containing phospholipid and ultrasound contrast enhancement
05/19/1998US5753521 Molecular cloning of genomic and CDNA sequences encoding cellular receptors for poliovirus
05/19/1998US5753504 Using antibodies for inhibiting lipopolysaccharide binding protein mediated lipopolysaccharide-dependent secretion of tumor necrosis factor from myeloid cells
05/19/1998US5753450 Bone resorption assay
05/19/1998US5753204 Imaging antigens, polypeptides and binding
05/14/1998WO1998020159A1 Representations of bimolecular interactions
05/14/1998WO1998019714A1 Mouse lacking heart-muscle adenine nucleotide translocator protein and methods
05/14/1998WO1998019713A1 Echogenic coating containing gaseous spaces for ultrasonography
05/14/1998WO1998019712A1 Methods for regulating angiogenesis
05/14/1998WO1998004292A3 Polymer-lipid microencapsulated gases for use as imaging agents
05/14/1998WO1998000172A3 Compositions and methods for altering the biodistribution of biological agents
05/14/1998DE19646037A1 Dentine/enamel adhesion promoter compositions, for filling of prepared dental cavities
05/14/1998DE19641197A1 Ionenpaare, Verfahren zu ihrer Herstellung und ihre Verwendung als Kontrastmittel Ion pairs, to processes for their preparation and their use as contrast agents
05/14/1998CA2271205A1 Echogenic coating containing gaseous spaces for ultrasonography
05/13/1998EP0840727A1 3-hydroxy-2(1h)-pyridinone chelating agents
05/13/1998EP0840570A2 Apparatus and method for making gas-filled vesicles of optimal size
05/13/1998CN1181751A Prepn. of N-arylmethyl axiridine derivatives, 1, 4, 7, 10 -Tetraazacyclododecane derivatives obtained therefrom and N -arylmethyl -ethanol -amine sulphonate esters as intermediates
05/13/1998CN1038328C Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their prepn.
05/12/1998US5750722 Method for the preparation of high purity substituted benz E! indoles and the alkaline salts thereof
05/12/1998US5750660 Contrast agents; medical diagnosis
05/12/1998US5750654 Leukaemia inhibitory factor
05/12/1998US5750351 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
05/12/1998US5750088 Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals
05/07/1998WO1998018919A2 Gabaa receptor subunit epsilon-related protein
05/07/1998WO1998018501A2 Improvements in or relating to diagnostic/therapeutic agents
05/07/1998WO1998018500A2 Improvements in or relating to diagnostic/therapeutic agents
05/07/1998WO1998018498A2 Improvements in or relating to diagnostic/therapeutic agents
05/07/1998WO1998018497A2 Contrast agents
05/07/1998WO1998018496A2 Contrast agents
05/07/1998WO1998018495A2 Improvements in or relating to diagnostic/therapeutic agents
05/07/1998WO1998018482A1 Use of lh-rh antagonists as diagnostic agent
05/07/1998WO1998018480A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes
05/07/1998WO1998018398A1 Method for improved selectivity in photo-activation and detection of molecular diagnostic agents
05/07/1998WO1998018387A1 Instrument having enhanced ultrasound visibility
05/07/1998WO1998010800A3 Labelled elastase inhibitors
05/07/1998WO1998003159A3 Lipid-binding proteins and their therapeutic and diagnostic use
05/07/1998DE19644994A1 Diagnostisches Mittel Diagnostic agent
05/07/1998CA2270120A1 Improvements in or relating to diagnostic/therapeutic agents
05/07/1998CA2269985A1 Improvements in or relating to diagnostic/therapeutic agents
05/07/1998CA2252782A1 Method for improved selectivity in photo-activation and detection of molecular diagnostic agents
05/06/1998EP0839058A2 In vivo diabetes test
05/06/1998EP0839057A1 Mr contrast agent
05/06/1998EP0839051A1 Fluorogenic substrates for diagnosis and photodynamic treatment of tumours
05/06/1998EP0788364A4 Treatment of urogenital cancer with boron neutron capture therapy
05/06/1998EP0711355A4 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors
05/05/1998US5747641 Tat-derived transport polypeptide conjugates
05/05/1998US5747541 Substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic agent, and medicament comprising them
05/05/1998US5747250 Probe for tumour diagnostics or tumour therapy
05/05/1998US5747047 Purified mite allergen
05/05/1998US5747000 Use of macrocyclic metal complexes as temperature sensors
05/05/1998US5746998 Targeted co-polymers for radiographic imaging
1 ... 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 ... 354